Biosensors Industry

The global biosensors market was valued at USD 30.0 billion in 2024 and is projected to grow at a compound annual growth rate (CAGR) of 8.6% from 2025 to 2030. The demand for biosensors is rising due to their diverse applications in medicine, the increasing prevalence of diabetes, the growing need for compact diagnostic devices, and continuous advancements in technology. Accurate and early diagnosis of diseases plays a critical role in improving the prognosis and survival rates of patients. In recent years, there has been a significant surge in demand for devices that are disposable, easy to use, cost-effective, and provide rapid response times. The emergence of COVID-19 positively impacted the medical device industry, with a variety of methods being used to scan for early symptoms of the virus.

The biosensors market is poised for substantial growth, driven by technological innovations and strategic initiatives by key market players. For example, in January 2023, Intricon, a company focused on developing and manufacturing medical devices with smart miniaturized electronics, made a significant move by opening a Biosensors Center of Excellence (CoE). This strategic decision underscores Intricon’s commitment to combining its technical expertise and capabilities within a vertically integrated business unit that focuses on bringing biosensor devices to the medical market. Such efforts, blending innovation with strategic goals, are fueling positive growth in the biosensors market.

Nanotechnology-based biosensors are expected to have a broad range of applications across industries, including food analysis, imaging, and microbial activity monitoring. The global biosensors market is becoming more consolidated due to a growing preference for non-invasive biosensors, the rising demand for medical devices and specialty drugs, and increasing research collaborations and contracts between various manufacturers. For instance, Ethicon Endo-Surgery Inc., under contracts managed by Johnson Johnson Innovation, is contributing to the expansion of the market. Additionally, the rising awareness about the importance of continuous health monitoring is also driving growth in the industry. As a result, the interest in biosensors among athletes is increasing. Many athletes use Electromyography (EMG) biosensors to monitor their health closely and receive alerts if any abnormalities occur.

Curious about the Biosensors Market, Download your FREE sample copy now and get a sneak peek into the latest insights and trends.

Frequently Asked Questions About This Report

1. What is the current size of the biosensors market?

• The biosensors market was valued at USD 30.0 billion in 2024 and is projected to grow at a compound annual growth rate (CAGR) of 8.6% from 2025 to 2030. This growth is fueled by technological advancements, the increasing prevalence of diseases like diabetes, the demand for compact and convenient diagnostic devices, and the rising need for early disease diagnosis.

2. What are the main factors driving growth in the biosensors market?

• Several factors are contributing to the market's growth:
• Diversity of medical applications: Biosensors are being used for a wide range of applications in diagnostics, disease management, and monitoring.
• Increasing number of diabetic patients: The rising global incidence of diabetes is driving demand for glucose monitoring and other diagnostic devices.
• High demand for compact diagnostic devices: Consumers are seeking smaller, more portable devices that are easy to use and offer rapid results.
• Technological advancements: Continuous improvements in biosensor technology are making these devices more accurate, efficient, and affordable.
• Pandemic impact: The COVID-19 pandemic increased the adoption of various biosensor technologies for rapid detection of symptoms.

3. How does the COVID-19 pandemic influence the biosensors market?

• The COVID-19 pandemic had a positive impact on the medical device sector, including biosensors. Early detection and monitoring of symptoms using biosensor technologies became crucial, spurring the adoption of rapid diagnostic devices. This, in turn, accelerated innovation in the biosensors market, leading to more efficient and effective products for disease monitoring.

4. What are some recent advancements in the biosensors market?

• Significant technological advancements are happening in the biosensors market. For instance, in January 2023, Intricon opened a Biosensors Center of Excellence (CoE), focusing on integrating its expertise in miniaturized electronics with biosensor development. Such initiatives are driving innovation and positioning key players to make strides in bringing advanced biosensor devices to the medical market.

5. What role does nanotechnology play in the biosensors market?

• Nanotechnology-based biosensors are anticipated to have widespread applications in industries beyond healthcare, including food analysis, imaging, and monitoring microbial activity. Nanotechnology enhances the sensitivity, efficiency, and miniaturization of biosensors, making them more effective for a variety of uses across different sectors.

6. Which industries are adopting biosensors?

• The biosensors market is expanding across several industries:
• Healthcare and diagnostics: Medical applications such as glucose monitoring, disease detection, and continuous health monitoring are some of the leading areas for biosensor use.
• Food industry: Biosensors are being increasingly utilized for food safety, quality control, and analysis.
• Athletics and fitness: Biosensors like Electromyography (EMG) are gaining popularity among athletes to monitor health, muscle activity, and performance in real-time.

Order a free sample PDF of the Biosensors Market Intelligence Study, published by Grand View Research.